New: Introducing the Finviz Crypto Map

Learn More

Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480

By Noor Ul Ain Rehman | July 25, 2025, 11:28 PM

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best strong buy healthcare stocks to buy now. On July 23, Evercore ISI raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $525 from $480, keeping an Outperform rating on the shares.

Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market
A workstation in a research lab stocked with laboratory products and services.

The firm told investors in a research note that while some anticipated a beat after Danaher’s print, concerns existed regarding whether FY2026 estimates were too high.

It further stated that Thermo Fisher Scientific Inc. (NYSE:TMO) adopted the right approach by giving color on FY26/FY27, and added that it expects FY 2025 to have some upside, potentially from the US and China as trends appear to be coming inline to better.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Latest News

Jul-25
Jul-25
Jul-24
Jul-24
Jul-24
Jul-24
Jul-24
Jul-24
Jul-23
Jul-23
Jul-23
Jul-23
Jul-23
Jul-23
Jul-23